Cervical Vertebral Spondylomyelopathy (Wobbler Syndrome)

Cervical vertebral spondylomyelopathy (CVSM), commonly known as Wobbler syndrome, is a multifactorial disorder of the cervical spinal cord characterized by compression of the cervical spinal cord and/or nerve roots due to congenital or acquired vertebral and ligamentous abnormalities. It primarily affects large and giant-breed dogs, leading to progressive ataxia, weakness, and proprioceptive deficits, typically in the pelvic limbs, with variable thoracic limb involvement. The condition encompasses two main clinical and pathological forms: a congenital/developmental form seen in young, large-breed dogs (e.g., Great Danes, Doberman Pinschers) and an acquired degenerative form seen in older, large-breed dogs (e.g., Doberman Pinschers, Rottweilers). The term 'wobbler' derives from the characteristic unsteady, 'wobbly' gait observed in affected animals. The syndrome is a leading cause of cervical myelopathy in large-breed dogs and requires a systematic diagnostic approach to differentiate it from other spinal cord disorders.

The exact etiology of CVSM is multifactorial and not fully understood. Several factors contribute to the development of the condition, including genetic predisposition, nutritional factors, rapid growth, and biomechanical stress. In the congenital/developmental form, a genetic basis is strongly suspected, with a heritable component identified in Great Danes and Doberman Pinschers. Nutritional factors, such as excessive caloric intake and calcium supplementation during growth, have been implicated in the development of cervical vertebral malformations and spinal cord compression. In the acquired degenerative form, chronic intervertebral disc degeneration, ligamentous hypertrophy (especially of the dorsal longitudinal ligament and ligamentum flavum), and articular facet joint osteoarthritis lead to spinal cord compression. The pathophysiology involves a combination of static and dynamic compression, where the spinal cord is compressed by vertebral malformations, disc protrusions, or soft tissue hypertrophy, and further compromised by flexion or extension of the neck. Traumatic events may exacerbate pre-existing lesions. Additionally, a component of vascular compromise and ischemia to the spinal cord may contribute to the clinical signs.

CVSM predominantly affects large and giant-breed dogs, with a higher incidence in Doberman Pinschers, Great Danes, Rottweilers, Bernese Mountain Dogs, and Weimaraners. The congenital/developmental form typically presents in young dogs between 6 months and 3 years of age, with Great Danes being the most commonly affected breed. The acquired degenerative form is more common in older dogs, typically over 3 years of age, with Doberman Pinschers having a median age of onset around 6-7 years. There is no strong sex predilection, though some studies suggest a slight male predominance. The condition is less commonly reported in cats, where it is often associated with congenital vertebral anomalies. The prevalence in the general dog population is low, but among large-breed dogs, it represents a significant cause of cervical myelopathy. Geographic variation is not well-documented, but the condition is recognized worldwide. The genetic basis is supported by familial clustering in certain breeds, and breeding of affected animals is discouraged.

The pathophysiology of CVSM involves compression of the cervical spinal cord, leading to mechanical injury, vascular compromise, and secondary neurodegenerative changes. The compression can be static, due to vertebral malformations (e.g., vertebral body malformation, stenosis of the vertebral canal), or dynamic, due to instability or abnormal movement of the vertebrae. In the congenital form, vertebral malformations such as vertebral body hypoplasia, malformed articular facets, and dorsal lamina abnormalities result in a narrowed vertebral canal and spinal cord compression. In the acquired form, chronic intervertebral disc degeneration leads to disc protrusion or extrusion, often at the C5-C6 or C6-C7 intervertebral spaces. Hypertrophy of the dorsal longitudinal ligament and ligamentum flavum, along with articular facet joint osteoarthritis, contributes to soft tissue compression. The compression can be exacerbated by neck flexion or extension, leading to dynamic compression. The spinal cord undergoes demyelination, axonal degeneration, and neuronal loss at the site of compression. Vascular compromise, including venous congestion and arterial ischemia, exacerbates the injury. The clinical signs reflect the dysfunction of the ascending and descending spinal cord tracts, particularly the proprioceptive pathways and upper motor neuron pathways to the pelvic limbs. The thoracic limbs may be affected due to compression of the cervical nerve roots or the lower motor neuron cell bodies in the cervical intumescence.

Predisposing factors for CVSM include genetic susceptibility, particularly in breeds such as Great Danes and Doberman Pinschers. Rapid growth and excessive body weight during puppyhood are significant risk factors, especially in giant breeds. Nutritional factors, such as high-calorie diets and calcium supplementation, have been implicated in the development of vertebral malformations. Trauma to the cervical spine may precipitate or exacerbate clinical signs. Concurrent orthopedic conditions, such as hip dysplasia, may alter gait and biomechanics, potentially increasing stress on the cervical spine. In older dogs, degenerative changes such as intervertebral disc disease and spondylosis deformans are predisposing factors. Additionally, certain conformational traits, such as a long neck and heavy head, may increase biomechanical stress on the cervical vertebrae. The role of exercise and activity level is not fully understood, but high-impact activities may contribute to the progression of the disease.

Clinical signs of CVSM are progressive and typically begin with a mild pelvic limb ataxia and weakness, which may be subtle and initially attributed to orthopedic disease. The classic 'wobbly' gait is characterized by a wide-based stance, hypermetria, and proprioceptive deficits in the pelvic limbs. As the disease progresses, the thoracic limbs may also show signs of weakness, muscle atrophy, and proprioceptive deficits. In severe cases, tetraplegia may occur. Neck pain is variable and may be present, especially in cases with acute disc extrusion or nerve root compression. Cranial nerve deficits are uncommon but may occur with high cervical lesions. Urinary and fecal incontinence can occur in advanced cases. The onset can be insidious or acute, with acute presentations often associated with trauma or disc extrusion. Physical examination reveals general proprioceptive ataxia, reduced postural reactions (e.g., proprioceptive positioning, hopping) in the pelvic limbs, and often in the thoracic limbs. Spinal reflexes are typically normal to exaggerated in the pelvic limbs (upper motor neuron signs), while the thoracic limbs may show lower motor neuron signs (e.g., reduced withdrawal reflex) if the lesion involves the cervical intumescence. Cervical hyperesthesia may be elicited on palpation or manipulation of the neck.

Differential diagnoses for CVSM include: 1) Intervertebral disc disease (IVDD) - particularly cervical disc extrusion, which can cause similar signs but often has a more acute onset and is more common in chondrodystrophic breeds; MRI or CT can differentiate. 2) Spinal cord neoplasia (e.g., meningioma, glioma, lymphoma) - typically progressive, with MRI showing a contrast-enhancing mass. 3) Meningomyelitis (infectious or immune-mediated) - may present with fever, neck pain, and CSF abnormalities; MRI may show intramedullary or meningeal enhancement. 4) Fibrocartilaginous embolic myelopathy (FCEM) - acute, non-progressive onset, often asymmetric; MRI may show a focal intramedullary lesion. 5) Atlantoaxial instability - more common in toy breeds, with neck pain and acute tetraplegia; radiographs or CT show atlantoaxial subluxation. 6) Cervical spinal cord trauma - history of trauma, acute onset, imaging may show vertebral fractures or luxation. 7) Degenerative myelopathy - typically affects older large-breed dogs, with progressive pelvic limb ataxia and upper motor neuron signs, but no neck pain; MRI may show spinal cord atrophy. 8) Syringomyelia - often associated with Chiari-like malformation, with signs of neck pain, scoliosis, and phantom scratching; MRI shows fluid-filled cavities in the spinal cord. 9) Discospondylitis - infection of the intervertebral disc and adjacent vertebrae, with neck pain and fever; radiographs or CT show lysis and collapse of the disc space. 10) Spinal epidural empyema - infection in the epidural space, with fever, neck pain, and rapid progression; MRI shows epidural collection.

The diagnostic approach to CVSM begins with a thorough history and physical examination, including a complete neurological examination to localize the lesion to the C1-C5 or C6-T2 spinal cord segments. If a cervical myelopathy is suspected, the next step is imaging. Survey radiographs of the cervical spine may reveal vertebral malformations, disc space narrowing, or spondylosis, but they are not sensitive for spinal cord compression. Advanced imaging, preferably MRI, is the gold standard for diagnosis. MRI provides detailed visualization of the spinal cord, intervertebral discs, ligaments, and vertebral canal, allowing identification of the site and cause of compression. CT with myelography is an alternative when MRI is unavailable, but it is less sensitive for soft tissue detail. Cerebrospinal fluid (CSF) analysis is recommended to rule out inflammatory or infectious diseases, especially if MRI findings are equivocal. Electromyography and nerve conduction studies may be helpful in assessing nerve root involvement but are not routinely performed. The diagnostic algorithm should also include a thorough orthopedic examination to rule out concurrent orthopedic disease, as many affected dogs also have hip dysplasia or other joint issues. In cases where surgery is planned, advanced imaging is essential for surgical planning.

Laboratory findings in CVSM are typically unremarkable, as the condition is primarily structural. Complete blood count (CBC) and serum biochemistry are usually within normal limits, unless there is a concurrent inflammatory or infectious process. CSF analysis may show mild albuminocytologic dissociation (elevated protein with normal cell count) in some cases, but this is non-specific. Inflammatory CSF (pleocytosis) would suggest meningitis or myelitis, which would be a differential diagnosis. Serology or PCR for infectious agents (e.g., Neospora, Toxoplasma, Ehrlichia, Borrelia) may be considered if infectious myelitis is suspected. Genetic testing for specific mutations associated with CVSM is not currently available, but research is ongoing. In cases with concurrent orthopedic disease, radiographs of the hips and stifles may be indicated. Overall, laboratory tests are primarily used to rule out other causes of myelopathy and to assess the patient's overall health status for anesthesia and surgery.

Imaging is essential for the diagnosis of CVSM. Survey radiographs of the cervical spine may show vertebral body malformations, such as a funnel-shaped vertebral canal, narrowing of the intervertebral disc spaces, and spondylosis deformans. However, radiographs are not sensitive for detecting spinal cord compression. Myelography, which involves injection of contrast medium into the subarachnoid space, can demonstrate compression but is invasive and has been largely replaced by advanced imaging. Computed tomography (CT) provides excellent bony detail and can identify vertebral malformations, stenosis, and disc mineralization, but it is less sensitive for soft tissue compression. CT myelography combines CT with intrathecal contrast to improve visualization of the spinal cord. Magnetic resonance imaging (MRI) is the imaging modality of choice, as it provides superior soft tissue contrast, allowing visualization of the spinal cord parenchyma, intervertebral discs, ligaments, and thecal sac. MRI findings in CVSM include spinal cord compression due to disc protrusion, ligamentous hypertrophy, or vertebral malformation, often at C5-C6 or C6-C7. T2-weighted images may show increased signal intensity within the spinal cord, indicating edema, gliosis, or myelomalacia. The degree of compression can be graded, and dynamic compression can be assessed with flexion and extension views. MRI is also useful for surgical planning, as it delineates the exact site and extent of compression.

Cytology and histopathology are not typically performed for the diagnosis of CVSM, as the condition is structural and diagnosed by imaging. However, if surgery is performed, tissue samples may be taken for histopathological examination. Histopathology of the spinal cord at the site of compression may show demyelination, axonal degeneration, Wallerian degeneration, and gliosis. In chronic cases, there may be neuronal loss and fibrosis. The intervertebral discs may show degenerative changes, such as chondroid metaplasia and fibrosis. Ligamentous hypertrophy is characterized by increased collagen and fibrocartilage. These findings are non-specific but support the diagnosis. CSF analysis, which is a form of cytology, may be performed to rule out inflammatory conditions. CSF from dogs with CVSM is typically normal or shows mild protein elevation. If a neoplastic process is suspected, cytology of a fine-needle aspirate or biopsy may be indicated, but this is not part of the routine diagnostic workup for CVSM.

Treatment of CVSM can be medical or surgical, depending on the severity of clinical signs, the cause of compression, and the presence of dynamic factors. Medical management is often recommended for dogs with mild clinical signs or those that are not surgical candidates. Medical therapy includes strict rest and confinement to reduce neck movement, weight management to reduce biomechanical stress, and the use of a neck brace or cervical collar to limit motion. Non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids may be used to reduce spinal cord inflammation and pain. Gabapentin or pregabalin may be used for neuropathic pain. Muscle relaxants, such as methocarbamol, may help reduce muscle spasms. Physical therapy, including controlled exercise and hydrotherapy, can help maintain muscle mass and improve gait. Surgical treatment is indicated for dogs with moderate to severe clinical signs, progressive disease, or when medical management fails. Surgical options include ventral slot decompression, dorsal laminectomy, and vertebral stabilization (e.g., distraction-fusion). The choice of surgery depends on the location and cause of compression. Ventral slot decompression is commonly used for disc-associated compression at C5-C6 or C6-C7. Dorsal laminectomy is used for dorsal compression due to ligamentous hypertrophy or vertebral malformation. Vertebral stabilization is used for dynamic compression or instability. Postoperative care includes pain management, antibiotics, and restricted activity for several weeks. The prognosis for surgical treatment is generally good, with improvement in 70-80% of cases, but complications such as infection, implant failure, and worsening of neurological signs can occur.

The prognosis for CVSM varies depending on the severity of clinical signs, the underlying cause, and the treatment modality. For dogs with mild clinical signs treated medically, the prognosis is fair, with many dogs stabilizing or improving, but progression is common over time. For dogs with moderate to severe signs, surgical treatment offers a better prognosis, with improvement reported in 70-80% of cases. The prognosis is worse for dogs with severe neurological deficits, such as tetraplegia, or those with a long duration of signs. Negative prognostic indicators include the presence of spinal cord hyperintensity on T2-weighted MRI, which indicates myelomalacia, and the presence of concurrent spinal cord atrophy. The recurrence rate after surgery is low, but some dogs may develop new compressive lesions at other sites. The overall mortality rate is low, but euthanasia may be considered in cases with severe, progressive disease that is unresponsive to treatment. Long-term management requires weight control, exercise restriction, and regular monitoring for recurrence of signs.

Follow-up care for dogs with CVSM is essential to monitor response to treatment and detect recurrence. For dogs treated medically, re-evaluation should be performed every 4-6 weeks initially, then every 3-6 months. Neurological examinations should be repeated to assess improvement or progression. For dogs treated surgically, re-evaluation is typically performed at 2 weeks, 6 weeks, and 3 months postoperatively, then every 6 months. Imaging, such as MRI, may be repeated if there is a lack of improvement or worsening of signs. Serial neurological examinations are the primary tool for monitoring. Weight management should be emphasized, and a weight loss program should be implemented if the dog is overweight. Physical therapy and rehabilitation should be continued as needed. Owners should be educated on the signs of recurrence, such as worsening ataxia or neck pain, and advised to seek immediate veterinary attention if these occur. Long-term management may include ongoing use of medications, such as gabapentin, and dietary modifications to maintain a healthy weight.

Pearls: 1) Always perform a thorough neurological examination to localize the lesion; CVSM typically causes upper motor neuron signs in the pelvic limbs and may cause lower motor neuron signs in the thoracic limbs if the lesion is at C6-T2. 2) MRI is the gold standard for diagnosis; do not rely solely on radiographs. 3) Consider concurrent orthopedic disease, as many large-breed dogs with CVSM also have hip dysplasia or other joint issues. 4) In young Great Danes, suspect congenital CVSM; in older Dobermans, suspect disc-associated compression. 5) Medical management can be effective for mild cases, but surgical decompression is often necessary for moderate to severe cases. Pitfalls: 1) Misdiagnosing CVSM as orthopedic disease, leading to delayed treatment. 2) Failing to perform advanced imaging, resulting in missed diagnosis. 3) Overlooking dynamic compression, which may require flexion/extension MRI to detect. 4) Using corticosteroids without a definitive diagnosis, which may mask signs and delay appropriate treatment. 5) Not addressing weight management, which can exacerbate clinical signs. 6) Performing surgery without adequate imaging, leading to incorrect surgical site or technique.

Medical management of CVSM may include the following drug protocols based on Plumb's Veterinary Drug Handbook: 1) Non-steroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation: Carprofen (2.2 mg/kg PO q12h or 4.4 mg/kg PO q24h), Meloxicam (0.1-0.2 mg/kg PO q24h), or Robenacoxib (1-2 mg/kg PO q24h). Use with caution in dogs with renal or hepatic disease. 2) Corticosteroids for severe inflammation: Prednisone (0.5-1 mg/kg PO q12h, tapering over 2-4 weeks) or Dexamethasone (0.1-0.2 mg/kg IV or SC q24h). Monitor for gastrointestinal ulceration and other side effects. 3) Gabapentin for neuropathic pain: 10-20 mg/kg PO q8-12h, starting at a lower dose and titrating up. 4) Pregabalin (alternative to gabapentin): 2-4 mg/kg PO q8-12h. 5) Muscle relaxants: Methocarbamol (20-40 mg/kg PO q8h) or Diazepam (0.5-2 mg/kg PO q8h) for muscle spasms. 6) Gastroprotectants if corticosteroids are used: Omeprazole (0.5-1 mg/kg PO q24h) or Famotidine (0.5-1 mg/kg PO q12h). 7) Antibiotics are not indicated unless there is a concurrent infection. Dosages should be adjusted for renal or hepatic impairment, and drug interactions should be considered. Always monitor for adverse effects, especially with long-term use.

Evidence-based literature on CVSM includes several key studies and consensus statements. A landmark study by da Costa et al. (2006) evaluated the clinical and MRI findings in Doberman Pinschers with CVSM, identifying disc-associated compression as the most common cause. Another study by De Decker et al. (2012) compared medical and surgical treatment outcomes, finding that surgical treatment led to better neurological improvement in dogs with moderate to severe signs. A systematic review by Jeffery et al. (2013) concluded that MRI is essential for diagnosis and surgical planning. The ACVIM consensus statement on the diagnosis and treatment of CVSM (da Costa et al., 2016) provides guidelines for diagnostic imaging and treatment options. Studies have also investigated the genetic basis of CVSM in Great Danes, with a genome-wide association study identifying potential candidate genes (e.g., COL9A2). The use of advanced imaging, particularly MRI, has improved diagnostic accuracy and surgical outcomes. Overall, the evidence supports a multimodal approach, with surgical decompression being the preferred treatment for moderate to severe cases, and medical management for mild cases or as a palliative option.